Dr. Gerhard Mann

OCUVITE macula capsules 84 pc age related macular degeneration treatment

OCUVITE macula capsules 84 pc age related macular degeneration treatment

Regular price £166.90 GBP
Regular price £200.00 GBP Sale price £166.90 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.
Well-cared for eyes with Ocuvite ® Makula anthocyanins from blueberry extract
Ocuvite ® Makula is used for the dietary treatment of age-related macular degeneration (AMD). The clinically tested vitamin B combination also contributes to a normal homocysteine ​​metabolism. 1

The product Ocuvite ® Makula anthocyanins from blueberry extract, related macular degeneration treatment at a glance:
  • patented vitamin complex
  • Vitamin B6, B12 and folic acid
  • scientifically tested
  • only 1 capsule a day

Ocuvite ® Makula related macular degeneration treatment also contains :
  • 14 mg lutein plus zeaxanthin
  • valuable anthocyanins from blueberry extract

Ocuvite ® Macula contains a scientifically based selection of micronutrients. The main component is a patented vitamin complex consisting of B6, B12 and folic acid, combined with the carotenoids lutein, zeaxanthin and blueberry extract. Degenerative processes in the macula cannot be prevented, but they can be delayed by supporting the metabolism there by taking antioxidants and promoting good blood circulation.

Ocuvite ® Makula related macular degeneration treatment RISK FACTOR: HIGH HOMOCYSTONE LEVEL
  • triggers more oxidative stress
  • promotes the accumulation of blood platelets and fibrin (plaques) in the vessels
  • reduces the elasticity of the vessels
  • affects the blood flow to the retina in the eye
  • promotes the progression of AMD

How does the eye work?
The human eye is built similarly to what we know from a camera. The light-sensitive cells are located on the retina. It is comparable to the film in a camera. Your cells pick up the light stimuli and transmit the visual impressions to the brain in the form of nerve signals.
2. The "rods" are important for black and white vision and for the field of vision outwards.

The cones are located in the optical axis of the eye, i.e. in the center of the retina.

This area is also known as the “yellow spot” or “macula lutea”, or macula for short. The macula is therefore the place of “central vision”.

What you should know about age-related macular degeneration (AMD)
Age-related macular degeneration is a widespread retinal disease.
It usually does not develop before the age of 50.
The risk of illness increases with age.
AMD does not cause pain and often develops unnoticed. It usually only slightly affects the eyesight in the early stages.

There are risk factors that increase the risk of the disease: increasing age and a family history of AMD are among the essential factors that cannot be influenced. Smoking, sunlight and an unbalanced diet and an increased homocysteine ​​level in the blood, on the other hand, are factors that can be influenced. With appropriate measures, you can make a valuable contribution to the health of your eyes.

The causes of AMD are diverse and have not yet been clearly clarified. Oxidative stress, an increasing deposition of waste products (drusen) under the retina and impaired blood circulation play an important role in the development of the disease. Ultimately, the supply situation of the photoreceptor cells deteriorates and the oxidative stress increases. This leads to an impairment or degeneration of the light-sensitive cells in the area of ​​the macula.

If there is an AMD disease, the first visual disturbances are heralded by the fact that the affected eye no longer perceives straight lines as straight, but increasingly as irregular - sometimes interrupted, sometimes with small jagged edges.
If the disease progresses, these visual disturbances increase and an opaque veil often covers the middle of the vision.

What you should know about oxidative stress, homocysteine ​​and circulatory disorders of the eye
There are around 125 million light-sensitive photoreceptor cells on the retina.
They have their highest density in the macula. The complex metabolic processes and the constant exposure to UV and blue light from daylight lead to pronounced oxidative stress on the retina from so-called free radicals.

The metabolism and the need for oxygen and micronutrients are correspondingly high there. In order for the eye to remain healthy and to perform its tasks, it must always be supplied with sufficient blood.

If there is a circulatory disorder, oxygen and important nutrients such as B. Antioxidants no longer reach the eye in sufficient quantities. This can lead to deteriorating eyesight over the long term. One measure is to ensure that the eyes are properly supplied. A sufficient intake of antioxidants (such as anthocyanins, e.g. from blueberry extract) and carotenoids can contribute to this. These are typical food components, with the carotenoids lutein and zeaxanthin being concentrated in the human body, especially in the macula.

Ultimately, good blood circulation in the eye is important for adequate supply. Too much homocysteine ​​in the blood can impair the blood flow and thus the supply to the cells.

Homocysteine ​​is a cell toxin that is produced when protein is broken down and can damage the vascular wall. It can be found in the blood of every human being. While there are no or only very small amounts in the blood of newborns, the level tends to increase with age.

The homocysteine ​​level can be determined by a family doctor.

Ocuvite ® Makula related macular degeneration treatment FREQUENTLY ASKED QUESTIONS & ANSWERS
How should Ocuvite ® Makula be used?
Take 1 capsule daily with a meal with a little liquid. This recommended daily intake must not be exceeded.

How can Ocuvite ® Macula help the eyes?
The clinically tested vitamin B combination optimally supports the homocysteine ​​metabolism, which has a positive effect on age-related macular degeneration (AMD) and homocysteine-associated circulatory disorders.

How should Ocuvite ® Makula be stored ?
Please store the pack in a dry place, protected from light and not above 25 ° C.

1 Siegers CP et al. (Apr 2013) Lowering pathologically increased homocysteine ​​levels - results of a multicenter dose-finding study to determine an optimally effective preparation for lowering homocysteine ​​levels. Poster publication CAM-EXPO, Düsseldorf.

Ocuvite ® Makula related macular degeneration treatment Made for Bausch + Lomb, Dr. Gerhard Mann chem.-pharm. Fabrik GmbH, Brunsbütteler Damm 165-173, 13581 Berlin


Shipping & Returns


Care Instructions

View full details